VAREX IMAGING CORPORATION
Varex Imaging Corporation (VREX) designs and supplies X‑ray imaging components and subsystems used by medical, veterinary and industrial equipment makers. The company's products include X‑ray tubes, digital detectors and power electronics that feed into diagnostic imaging systems and non‑destructive testing machines. With a market capitalisation around $483.48M, Varex is positioned as a specialist supplier rather than an OEM, so revenue is linked to capital equipment cycles, hospital and clinical investment and industrial inspection demand. Investors should note drivers such as ageing populations, diagnostic upgrades and industrial automation, alongside risks including cyclical capital spending, pricing pressure from larger suppliers and supply‑chain sensitivity. The stock can be more volatile than large-cap healthcare names; values may rise or fall and past performance is not indicative of future returns. This summary is educational only and not personal financial advice — consider your risk tolerance, investment horizon and seek independent advice where appropriate.
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying Varex Imaging's stock, expecting it to rise to $17.20.
Financial Health
Varex Imaging is performing well with solid revenue and cash flow, although profit margins could improve.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Discover More Opportunities
Abbott
Abbott Laboratories is a global healthcare company that develops and markets a broad range of health care products, including medical devices, diagnostics, nutritionals, and branded generic pharmaceuticals.
AGILENT TECHNOLOGIES INC
Agilent Technologies, Inc. specializes in life sciences, diagnostics and applied markets, providing application-focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. Its segments include Life Sciences and Diagnostics Markets, Agilent CrossLab and Applied Markets. The Life Sciences and Diagnostics Markets segment provides contract development and manufacturing services for pharmaceutical customers as well as solutions that include reagents, instruments, software and consumables which enable customers in the clinical and life sciences research areas to interrogate samples at the cellular and molecular level. The Agilent CrossLab segment spans the entire lab with its services and consumables portfolio in addition to software and laboratory automation solutions, which are designed to improve customer outcomes and represent a range of offerings designed to serve customer needs across end-markets and applications.
ALIGN TECHNOLOGY INC
Align Technology is a medical device company that designs, manufactures and markets a range of dental and orthodontic products.
Baskets Featuring VREX
Corporate Fortress: Investing In Enhanced Security
A shooting at Blackstone's New York headquarters serves as a major catalyst for corporations to increase spending on safety. This creates a potential investment opportunity in companies that provide advanced security products and services.
Published: August 2, 2025
Explore BasketImmersive Rehab & VR Therapy
Virtual and augmented reality are transforming healthcare with innovative digital treatments for physical and psychological healing. These carefully selected companies are at the forefront of creating immersive technologies that offer effective alternatives to traditional therapies, poised to benefit from growing clinical acceptance.
Published: June 17, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Medical imaging demand
Ageing populations and diagnostic upgrades can drive steady demand for imaging components, though capital spending cycles can introduce volatility.
Component supplier role
Longstanding OEM relationships and specialised technology are strengths, but margins and order timing can vary with competitive and supply pressures.
Industrial and global reach
Sales span medical and industrial markets across regions, offering diversification, though global exposure brings currency and regulatory considerations.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
